The Lancet Oncology
Fecha de publicación: 20 July 2020
Autores: Camille Maringe, PhD., Prof James Spicer, PhD., Melanie Morris, PhD., Prof Arnie Purushotham, MD., Prof Ellen Nolte, PhD., Prof Richard Sullivan, PhD., et al.
Background: Since a national lockdown was introduced across the UK in March, 2020, in response to the COVID-19 pandemic, cancer screening has been suspended, routine diagnostic work deferred, and only urgent symptomatic cases prioritised for diagnostic intervention. In this study, we estimated the impact of delays in diagnosis on cancer survival outcomes in four major tumour types.Leer más